This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Oct;14(10):2687-90.

doi: 10.1245/s10434-007-9423-7. Epub 2007 Jul 27.

The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice

Yu Jo Chua, David Cunningham

PMID: 17653804
DOI: 10.1245/s10434-007-9423-7

Editorial

The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice

Yu Jo Chua et al. Ann Surg Oncol. 2007 Oct.

. 2007 Oct;14(10):2687-90.

doi: 10.1245/s10434-007-9423-7. Epub 2007 Jul 27.

Authors

Yu Jo Chua, David Cunningham

PMID: 17653804
DOI: 10.1245/s10434-007-9423-7

No abstract available

PubMed Disclaimer

Comment in

Perioperative chemotherapy for gastric cancer.
Catarci M, Carrara A. Catarci M, et al. Ann Surg Oncol. 2008 Apr;15(4):1253. doi: 10.1245/s10434-008-9814-4. Epub 2008 Feb 1. Ann Surg Oncol. 2008. PMID: 18239969 No abstract available.

Comment on

Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E, Fatouros M, Roukos DH. Briasoulis E, et al. Ann Surg Oncol. 2007 Oct;14(10):2691-5. doi: 10.1245/s10434-007-9358-z. Epub 2007 Jul 26. Ann Surg Oncol. 2007. PMID: 17653806 No abstract available.

Similar articles

Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E, Fatouros M, Roukos DH. Briasoulis E, et al. Ann Surg Oncol. 2007 Oct;14(10):2691-5. doi: 10.1245/s10434-007-9358-z. Epub 2007 Jul 26. Ann Surg Oncol. 2007. PMID: 17653806 No abstract available.
[Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study].
Lordick F, Siewert JR. Lordick F, et al. Chirurg. 2006 Dec;77(12):1166-7. doi: 10.1007/s00104-006-1249-5. Chirurg. 2006. PMID: 17091285 German. No abstract available.
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants. Cunningham D, et al. N Engl J Med. 2006 Jul 6;355(1):11-20. doi: 10.1056/NEJMoa055531. N Engl J Med. 2006. PMID: 16822992 Clinical Trial.
[Therapy in gastric cancer. From an oncological perspective].
Wilke H, Stahl M. Wilke H, et al. Chirurg. 2009 Nov;80(11):1023-7. doi: 10.1007/s00104-009-1735-7. Chirurg. 2009. PMID: 19902288 Review. German.
Neoadjuvant treatment of oesophageal adenocarcinoma.
Robb WB, Naughton P, Walsh TN. Robb WB, et al. Minerva Chir. 2004 Oct;59(5):461-70. Minerva Chir. 2004. PMID: 15494673 Review.

See all similar articles

Cited by

Application of FLEEOX Preoperative Chemotherapy via Intra-arterial and Intravenous Administration in Treatment of Unresectable Locally Advanced Gastric Cancer.
He Q, Li Y, Ma L, Ji X, Li G. He Q, et al. J Gastrointest Surg. 2016 Aug;20(8):1421-7. doi: 10.1007/s11605-016-3153-8. Epub 2016 Apr 25. J Gastrointest Surg. 2016. PMID: 27114248
Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma.
McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP, Wasif N. McGhan LJ, et al. J Gastrointest Surg. 2012 Jan;16(1):53-61; discussion 61. doi: 10.1007/s11605-011-1707-3. Epub 2011 Oct 5. J Gastrointest Surg. 2012. PMID: 21972055
Outcomes of locally advanced gastric and gastroesophageal adenocarcinoma cancers treated with neoadjuvant FLOT in a tertiary care hospital in Pakistan.
Dawood T, Rashid YA, Khan SR, Jabbar AA, Zahir MN, Moosajee MS. Dawood T, et al. Ecancermedicalscience. 2024 May 21;18:1705. doi: 10.3332/ecancer.2024.1705. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39021541 Free PMC article.
A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma.
Yi H, Yan X, Luo Q, Yuan L, Li B, Pan W, Zhang L, Chen H, Wang J, Zhang Y, Zhai Y, Qiu MZ, Yang DJ. Yi H, et al. J Exp Clin Cancer Res. 2018 May 2;37(1):97. doi: 10.1186/s13046-018-0765-8. J Exp Clin Cancer Res. 2018. PMID: 29716622 Free PMC article.
Clinicopathological correlation of insulin-like growth factor binding protein 3 and their death receptor in patients with gastric cancer.
Ansari A, Gheysarzadeh A, Sharifi A, Mofid MR. Ansari A, et al. Res Pharm Sci. 2024 Feb 6;19(1):42-52. doi: 10.4103/1735-5362.394819. eCollection 2024 Feb. Res Pharm Sci. 2024. PMID: 39006978 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information